Finally, our study identifies a potential high-risk subgroup of ALL with ARID5BlowPHF2low expression and reveals the oncogenic effect of ARID5BlowPHF2low expression and its correlation with Ikaros dysfunction in ALL. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.